107 related articles for article (PubMed ID: 33292291)
1. Increasing the information provided by probabilistic sensitivity analysis: The relative density plot.
Geenen JW; Vreman RA; Boersma C; Klungel OH; Hövels AM; Ham RMTT
Cost Eff Resour Alloc; 2020 Nov; 18(1):54. PubMed ID: 33292291
[TBL] [Abstract][Full Text] [Related]
2. Benefits of probabilistic sensitivity analysis - a review of NICE decisions.
Adalsteinsson E; Toumi M
J Mark Access Health Policy; 2013; 1():. PubMed ID: 27226828
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.
Andronis L; Barton P; Bryan S
Health Technol Assess; 2009 Jun; 13(29):iii, ix-xi, 1-61. PubMed ID: 19500484
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Some Health States Are Better Than Others: Using Health State Rank Order to Improve Probabilistic Analyses.
Goldhaber-Fiebert JD; Jalal HJ
Med Decis Making; 2016 Nov; 36(8):927-40. PubMed ID: 26377369
[TBL] [Abstract][Full Text] [Related]
7. The role of value-of-information analysis in a health care research priority setting: a theoretical case study.
Corro Ramos I; Rutten-van Mölken MP; Al MJ
Med Decis Making; 2013 May; 33(4):472-89. PubMed ID: 23275451
[TBL] [Abstract][Full Text] [Related]
8. Cost Recommendation under Uncertainty in IQWiG's Efficiency Frontier Framework.
Corro Ramos I; Lhachimi SK; Gerber-Grote A; Al MJ
Med Decis Making; 2017 Feb; 37(2):162-172. PubMed ID: 27005521
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective.
Aiello E; Bianculli PM; Bhattacharyya D; Gunda P; Citera G
Value Health Reg Issues; 2019 Dec; 20():86-94. PubMed ID: 31103950
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
[TBL] [Abstract][Full Text] [Related]
11. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
Freedland SJ; Kane CJ; Presti JC; Terris MK; Amling CL; Dorey F; Aronson WJ
J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
[TBL] [Abstract][Full Text] [Related]
12. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pouwels XGLV; Wolff R; Ramaekers BLT; Van Giessen A; Lang S; Ryder S; Worthy G; Duffy S; Armstrong N; Kleijnen J; Joore MA
Pharmacoeconomics; 2018 May; 36(5):533-543. PubMed ID: 29344794
[TBL] [Abstract][Full Text] [Related]
14. Epistemic uncertainty in the ranking and categorization of probabilistic safety assessment model elements: issues and findings.
Borgonovo E
Risk Anal; 2008 Aug; 28(4):983-1001. PubMed ID: 18554270
[TBL] [Abstract][Full Text] [Related]
15. Not simply more of the same: distinguishing between patient heterogeneity and parameter uncertainty.
Vemer P; Goossens LM; Rutten-van Mölken MP
Med Decis Making; 2014 Nov; 34(8):1048-58. PubMed ID: 25216723
[TBL] [Abstract][Full Text] [Related]
16. Nerve transfer versus muscle transfer to restore elbow flexion after pan-brachial plexus injury: a cost-effectiveness analysis.
Wali AR; Santiago-Dieppa DR; Brown JM; Mandeville R
Neurosurg Focus; 2017 Jul; 43(1):E4. PubMed ID: 28669295
[TBL] [Abstract][Full Text] [Related]
17. A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis.
Ren S; Minton J; Whyte S; Latimer NR; Stevenson M
Pharmacoeconomics; 2018 Mar; 36(3):341-347. PubMed ID: 29081060
[TBL] [Abstract][Full Text] [Related]
18. A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
Karnon J; Czoski-Murray C; Smith K; Brand C; Chakravarthy U; Davis S; Bansback N; Beverley C; Bird A; Harding S; Chisholm I; Yang YC
Health Technol Assess; 2008 Jun; 12(27):iii-iv, ix-124. PubMed ID: 18513468
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
